T he innovative methodology described in this paper, along with the discovery of the Haemophilus influenzae restriction enzyme by Smith and Wilcox (see above), set the stage for recombinant DNA technology as we know it today. Cohen and colleagues were the first to construct a recombinant plasmid. They showed that ligation of two EcoRI-digested DNA fragments from separate antibiotic resistance plasmids resulted in a functional hybrid replicon when transformed into Escherichia coli C600. Furthermore, Cohen et al. showed that the recombinant plasmids retained the genetic nucleotides from both of the parental DNA sources. It should be pointed out that the demonstration of nucleotide sequence homology between parent and recombinant plasmid DNA was a much harder undertaking in 1973 than it is today. Indeed, to provide such proof, Cohen and colleagues had to show by electron microscopic analyses that heteroduplex formation occurred between pSC109 and each of its component plasmids. 1977). The process of cleaving DNA with an enzyme, joining the restricted fragments to form a plasmid, transforming the recombinant plasmid into a bacterial host, and permitting growth of the transformants with subsequent amplification of the recombinant plasmid, constitutes the bread and butter of molecular-cloning technology. As one of our committee members asked about the methods described in this paper, "What technique could have possibly had a bigger single impact on how we do molecular analyses of microbes today?" ALISON O'BRIEN
